Timothy Eugene Sullivan - 29 Jan 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Financial Officer
Signature
/s/s David Watson, attorney-in-fact for Timothy Sullivan
Issuer symbol
APLS
Transactions as of
29 Jan 2025
Net transactions value
-$16,120
Form type
4
Filing time
30 Jan 2025, 12:15:46 UTC
Previous filing
23 Jan 2025
Next filing
11 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $16,120 -546 -0.42% $29.52 128,665 29 Jan 2025 Direct F1
holding APLS Common Stock 70,396 29 Jan 2025 The Timothy E Sullivan Irrevocable Trust of 2023 F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 28, 2025.
F2 The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.